US 11896643
Fibroblast binding agents and use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11896643 (Fibroblast binding agents and use thereof) held by Orionis Biosciences, Inc expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/704, A61K33/24